Education
About Us
Working with TipRanks
Follow Us
OSE Immunotherapeutics (FR:OSE)
:OSE
RESEARCH TOOLSreports
OSE Immunotherapeutics SA (6OP – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sean Lee CFA from H.C. Wainwright maintained a Buy rating
...Read more
OSE News on the Web
TipRanks News
Neutral
Simply Wall St
Neutral
Simply Wall St
Neutral
Simply Wall St
Neutral
TipRanks News
Neutral
Yahoo Finance
Neutral
Yahoo Finance
Neutral
Clinical Trials Arena
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is FR:OSE’s Media Buzz Sentiment?
Currently, no data Available
What is FR:OSE’s weekly average amount of articles?
Currently, no data Available
What is FR:OSE’s News Sentiment?
59% of articles about FR:OSE were positive this week, compared to its sector average of 55%.